NCT03762733Enrolling by invitation
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
Background: A person s blood, tissue, and other samples contain DNA. Cancer is a disease of cells that are not working properly. It is caused by changes in DNA that build up. Researchers want to do future studies on DNA changes This may help them learn how to guide treatment for cancer. They need biological samples like tumors, blood, and urine for these studies. Objective: To create a place to collect and store biological samples from people with gynecologic malignancies like breast cancer. Samples from certain relatives of theirs will be collected too. Eligibility: Adults ages 18 and older who are being seen at NIH for breast cancer or other gynecologic malignancy Their biological relatives of the same age Design: Participants will answer questions about their family history. Participants will have a physical exam and medical history. This will include questions about age, ethnicity, and disease history. They will also answer questions about their medical treatments and responses. Participants will give blood and urine samples. Participants may give a tumor tissue sample. This will not be taken specifically for this study. It will be from a previous procedure or one that is already planned. Other samples may be taken only if a procedure is required for treatment. These include bone marrow, cerebrospinal fluid, and other fluids. A group of doctors and other professionals will oversee the sample storage place. The group will review all requests to be sure the use of the specimens is valid.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 1 Dec 2018
- Start date
- 4 Jan 2022
- Primary completion date
- 29 Dec 2028
- Lead sponsor
- National Cancer Institute (NCI)
- Diseases
- Ovarian cancer
- NCT number
- NCT03762733
What you commit to
- Study type: Observational
- Planned participants: 500
- From 4 Jan 2022 to the primary completion date, 29 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Pregnant women are not eligible to take part; pregnancy will be assessed using clinical criteria (medical history and physical exam).
Criteria the registry did not label
- INCLUSION CRITERIA:
- Adult subject (age 18 and older) co-enrolled on a trial, or otherwise undergoing consultation, screening, or follow up on existing protocols conducted at the NIH Clinical Center, who are evaluated in the Women s Malignancies Branch Clinic.
- Participant or biological relative of a participant, as follows:
- Participant with a histologically confirmed breast cancer or other gynecologic malignancy; histopathology of the biopsy tissue must be
- confirmed by the NCI Laboratory of Pathology, prior to banking of the tissue on this protocol.
- Biological relative (1st -3rd degree) of a participant who meets the eligibility of histologically confirmed malignancy per above
- criterion.
- Subject willingness and ability to provide informed consent.
- Subject willingness to provide tissue samples for banking.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institutes of Health Clinical Center Coordinator of this site? Confirm its status | Bethesda | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.